• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERVASCULAR SAS CARDIOROOT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERVASCULAR SAS CARDIOROOT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number HEWROOT0032
Device Problems Material Frayed (1262); Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/21/2023
Event Type  Injury  
Manufacturer Narrative
(10/3233) a fragment of the involved product was returned to the manufacturer.A visual inspection will be performed.(4109/213) the review of historical data indicated that no other complaint was reported for the same sterilization lot number 22m08.(3331/3233) the device history records review is ongoing, results are pending.(11) the investigation is still ongoing.A follow-up report will be sent upon completion of the investigation.
 
Event Description
It was reporter to intervascular that, after making some adjustments to shape a cardioroot, the surgeon started putting suture to attach it and the suture tore through twice.It was indicated that the suture passed through the graft and the valve when the surgeon was tying it as usual, but the suture tore through the graft.The surgery was prolonged since they had to use a competitor's graft to resize and implant it to complete the case.There were no fragments left in the patient.No consequence was reported on the patient.The surgeon has previously used cardioroot twice before.
 
Manufacturer Narrative
(4111) blocks b5 was updated with additional information provided by the surgeon regarding the performed procedure and the instrument used.(3331/213) the device history records review concluded that no deviation was identified in relation with the reported event.(10/4248) a fragment of the device was returned to intervascular for inspection.Upon receipt, it was noticed that the graft has been cut at the level of the cardioroot bulge.A visual inspection performed by the quality assurance manager revealed that the product was not cut with a thermocautery as confirmed by the surgeon.Indeed, the constituent threads of the prosthesis are visible.To be noted that the following mention is present in the section directions for use of the current product instructions for use (ifu): ¿as with all the woven products, the intergard woven grafts should be cut with a low-temperature disposable cautery (e.G., ¿ 900°f / ¿ 500°c) to minimize fraying.¿ moreover, to be noted that the following mention is present as a warning in the ifu: "due to their intrinsic weaving pattern, woven grafts are more prone to fraying.Do not cut woven grafts with scissors or scalpels to limit the risk of graft fraying".Moreover, the product exhibits lacerations corresponding to the suture tear noticed by the surgeon.These lacerations may have been caused by the use of needles not recommended in the ifu.Please note that the following mention is present as a warning in the ifu: "use of taper cut or other cutting needles may damage the graft fibers." in conclusion, due to the product having been cut and weakened, it is not possible to determine the cause of the reported torn suture.(4112/3233) a medical assessment of the reported case will be performed.(11) the investigation is still ongoing.A follow-up report will be sent upon completion of the investigation.
 
Event Description
Complaint #(b)(4).Additional information provided by the initial reporter indicates the surgeon performed a redo-redo root procedure and used scissors to cut the bulge of the cardioroot.No information about the instrument used for suturing was provided.
 
Manufacturer Narrative
(4112) the case and its investigation have been reviewed by the medical affairs department whose assessment is below: "this complaint is regarding a cardioroot woven graft.While passing the first stitch through the graft the suture ¿cut¿ through the fabric.This maneuver was performed a second time and again the suture ¿cut¿ through the graft.After the second attempt, the surgeon decided to switch devices and instead used a terumo valsalva graft.The result of this was a prolonged operative time.The consequence for the patient was considered a serious injury due to the possibility of the device having been implanted without the surgeon identifying the weakened fabric.The surgeon, using the cardioroot graft only for the second time, used scissors to shape the graft against the specific warning included in the ifu.Use of scissors not recommended due to the intrinsic weaving pattern of the fabric that makes it more susceptible to fraying.Instead, woven pet should be cut with a low temperature disposable cautery as specified instructions for use of the ifu.Also mentioned: cutting needles, excessive tension should be avoided; and needle bites should be greater than 2mm from the cutting edge.It was not confirmed that a cutting needle was used; or that excessive tension was applied; or that bites were taken inside of 2mm from the cut edge.A fragment of the device was returned for inspection; the threads of the device were observed as well as lacerations linked to suture tear.The narrative of the surgeon explaining the method used to cut the device together with the analysis of the sample provided are strongly indicative of the fabric tearing due to fraying." (61) the outcome of the conducted investigation suggests that the most probable root cause of the event would be the use of scissors to cut the woven graft instead of the recommended thermocautery outlined in the current product instructions for use (ifu).As highlighted in the medical review, the method used to cut the device together with the examination of the sample provided are strongly indicative of the fabric tearing due to fraying.To be noted that, due to their intrinsic weaving pattern, woven grafts are more prone to fraying.As indicated in the ifu, a low temperature disposable cautery should be used to minimize fraying when cutting this graft.In accordance with our complaint procedures, customer will be specifically informed of this ifu recommendation, via the complaint response sent to the customer, in order to prevent recurrence of the use error.
 
Event Description
Complaint #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOROOT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
INTERVASCULAR SAS
zone industrielle athelia i
la ciotat 13705
FR  13705
Manufacturer (Section G)
INTERVASCULAR SAS
zone industrielle athelia i
la ciotat 13705
FR   13705
Manufacturer Contact
clemence vaneenoge
zone industrielle athelia i
la ciotat 13705
FR   13705
442084646
MDR Report Key17711848
MDR Text Key322973606
Report Number1640201-2023-00028
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00384401013921
UDI-Public(01)00384401013921
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K103347
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 10/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHEWROOT0032
Device Catalogue NumberHEWROOT0032
Device Lot Number22M08
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/07/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/16/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/08/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-